Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in percutaneous nephrolithotomy
IRCT20150420021869N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nephrolithiasis comparing Tranexamic acid group with Placebo group (2 arms). Primary endpoints: Hemoglobin drop, Number of transfusions and 2 more. Started Sep 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20150420021869N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150420021869N1.